OWINGS MILLS, Md., Sept. 8, 2016 /PRNewswire/ -- Medifast, Inc.
(NYSE: MED), a leading United
States manufacturer and provider of clinically proven
weight-loss and healthy living products and programs, announced
today that its Board of Directors has approved the declaration of a
$0.25 cash dividend to its
stockholders. The quarterly cash dividend of $0.25 per share is payable on November 10, 2016 to stockholders of record as of
the close of business on September
23, 2016.
The Company expects to maintain a program of paying dividends on
a quarterly basis. However, the declaration of dividends in
the future is subject to the discretion of the Medifast Board of
Directors, who will evaluate the Company's dividend program from
time to time based on factors that it deems relevant.
About Medifast®:
Medifast (NYSE: MED)
is the leading easy-to-use, clinically proven provider of
weight-loss and healthy living products and programs. Medifast aims
to help customers lead a healthier lifestyle through a holistic
approach to weight-loss and weight management, nutrition education
and fitness. Medifast's proven results are based on the use of
structured meal plans featuring Medifast Meals, which are
nutritionally designed to assist customers with successful
weight-loss and weight management. The company sells its
products and programs via four unique distribution channels: 1) the
web and national call centers, 2) the Take Shape For Life personal
coaching division, 3) Medifast Weight Control Centers,
and 4) a national network of physicians. The company also offers
sports nutrition products under the brand Dual Fuel™ Nutrition that
are formulated to provide athletes and active individuals with the
right balance of carbohydrates and high quality protein for top
performance. Medifast was founded in 1980 and is
located in Owings Mills, Maryland. For more information, log
onto www.MedifastNow.com.
MED-F
Forward Looking Statements
This release contains "forward-looking" statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
Section 21E of the Securities Exchange Act of 1934, as amended, and
the Private Securities Litigation Reform Act of 1995. These
"forward-looking" statements are based on present circumstances and
on Medifast's predictions with respect to events that have not
occurred, that may not occur, or that may occur with different
consequences and timing than those now assumed or
anticipated. Such forward-looking statements, including the
expected future payment of dividends and any statement of the plans
and objectives of management for future operations and forecasts of
future growth and value, are not guarantees of future performance
or results and involve risks and uncertainties that could cause
actual events or results to differ materially from the events or
results described in the forward-looking statements. Such
forward-looking statements are made only as of the date of this
release and Medifast assumes no obligation to update
forward-looking statements to reflect subsequent events or
circumstances. Readers should not place undue reliance on
these forward-looking statements.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/medifast-inc-announces-quarterly-dividend-300325146.html
SOURCE Medifast, Inc.